Targeting the Proliferation Inhibition of Chronic Myeloid Leukemia Cells by Bone Marrow Derived-Mesenchymal Stem Cells via ERK Pathway as a Therapeutic Strategy

Targeting the Proliferation Inhibition of Chronic Myeloid Leukemia Cells by Bone Marrow Derived-Mesenchymal Stem Cells via ERK Pathway as a Therapeutic Strategy

Bone marrow-derived mesenchymal stem cells (BMSCs) are of specific attention due to their potential clinical use in cell transplantation. These cells could secrete cytokines and growth factors upon stimulation or suppression in regenerative medicine. This study was to evaluate the influence of BMSCs...

Full description

Bibliographic Details
Main Authors:	Ezzatollah Fathi, Behnaz Valipour, Raheleh Farahzadi
Format:	Article
Language:	English
Published:	Tehran University of Medical Sciences 2020-08-01
Series:	Acta Medica Iranica
Subjects:	Bone marrow-derived mesenchymal stem cells (BMSCs) Chronic myeloid leukemia (CML) cell line Co-culture Extracellular-signal-regulated kinase (ERK) pathway
Online Access:	https://acta.tums.ac.ir/index.php/acta/article/view/8269

Similar Items

Mesenchymal Stem Cells as a Cell-Based Therapeutic Strategy Targeting the Telomerase Activity of KG1 Acute Myeloid Leukemia Cells
by: Ezzatollah Fathi, et al.
Published: (2022-02-01)

L-Carnitine Promotes Cardiomyogenic Differentiation of C-Kit+Bone Marrow Progenitor Cells via MAPK-ERK Signaling Pathway
by: Tina Daneshrad, et al.
Published: (2023-07-01)

Crosstalk between CML cells with HUVECs and BMSCs through exosomes
by: Zafer Cetin, et al.
Published: (2020-10-01)

AML alters bone marrow stromal cell osteogenic commitment via Notch signaling
by: Chiara Tomasoni, et al.
Published: (2023-12-01)

Norepinephrine Inhibits the Proliferation of Human Bone Marrow-Derived Mesenchymal Stem Cells via β2-Adrenoceptor-Mediated ERK1/2 and PKA Phosphorylation
by: Jessica Hedderich, et al.
Published: (2020-05-01)

Myeloid-derived suppressor cells in Chronic myeloid leukemia
by: Cesarina eGiallongo, et al.
Published: (2015-05-01)

PAK1 Mediates Bone Marrow Stromal Cell-Induced Drug Resistance in Acute Myeloid Leukemia via ERK1/2 Signaling Pathway
by: Banban Li, et al.
Published: (2021-07-01)

Butein Promotes Lineage Commitment of Bone Marrow-Derived Stem Cells into Osteoblasts via Modulating ERK1/2 Signaling Pathways
by: Basem M. Abdallah, et al.
Published: (2020-04-01)

The Yin and Yang of the Bone Marrow Microenvironment: Pros and Cons of Mesenchymal Stromal Cells in Acute Myeloid Leukemia
by: Marilena Ciciarello, et al.
Published: (2019-10-01)

GABP is necessary for stem/progenitor cell maintenance and myeloid differentiation in human hematopoiesis and chronic myeloid leukemia
by: Georgi Manukjan, et al.
Published: (2016-05-01)

Bone marrow stromal cells reduce low-dose cytarabine-induced differentiation of acute myeloid leukemia
by: Tomislav Smoljo, et al.
Published: (2023-10-01)

7-Ketocholesterol Promotes Oxiapoptophagy in Bone Marrow Mesenchymal Stem Cell from Patients with Acute Myeloid Leukemia
by: Jessica Liliane Paz, et al.
Published: (2019-05-01)

Leukemia stem cell-bone marrow microenvironment interplay in acute myeloid leukemia development
by: Yiyi Yao, et al.
Published: (2021-07-01)

Naringin enhances osteogenic differentiation through the activation of ERK signaling in human bone marrow mesenchymal stem cells
by: Huichao Wang, et al.
Published: (2017-04-01)

Alterations of adiponectin gene expression in bone marrow of acute myeloid leukemia
by: Seyed Hossein Abtahi, et al.
Published: (2020-04-01)

Acute Myeloid Leukemia and the Bone Marrow Niche—Take a Closer Look
by: Lena Behrmann, et al.
Published: (2018-10-01)

Metabolic Profiling during Acute Myeloid Leukemia Progression Using Paired Clinical Bone Marrow Serum Samples
by: Hyun Kyu Kim, et al.
Published: (2021-08-01)

Abnormal adipogenic signaling in the bone marrow mesenchymal stem cells contributes to supportive microenvironment for leukemia development
by: Rawan Sabbah, et al.
Published: (2023-10-01)

Bone marrow mesenchymal stem cells tune the differentiation of myeloid-derived suppressor cells in bleomycin-induced lung injury
by: XiaoSan Su, et al.
Published: (2018-09-01)

Chronic myeloid leukemia — before and after imatinib (First part)
by: E. G. Lomaia, et al.
Published: (2022-11-01)

Targeting the stem cell niche micro-environment as therapeutic strategies in aging
by: Raheleh Farahzadi, et al.
Published: (2023-05-01)

RanBP3 Regulates Proliferation, Apoptosis and Chemosensitivity of Chronic Myeloid Leukemia Cells via Mediating SMAD2/3 and ERK1/2 Nuclear Transport
by: Qian Li, et al.
Published: (2021-08-01)

Novel Mechanism by a Bis-Pyridinium Fullerene Derivative to Induce Apoptosis by Enhancing the MEK-ERK Pathway in a Reactive Oxygen Species-Independent Manner in BCR-ABL-Positive Chronic Myeloid Leukemia-Derived K562 Cells
by: Kazuya Sumi, et al.
Published: (2022-01-01)

Survival of Patients with CML on Imatinib Experience with 44 Iraqi Patients
by: Ali M. Jawad, et al.
Published: (2008-10-01)

A Role for the Bone Marrow Microenvironment in Drug Resistance of Acute Myeloid Leukemia
by: Seyed Mohammadreza Bolandi, et al.
Published: (2021-10-01)

Curculigoside Ameliorates Bone Loss by Influencing Mesenchymal Stem Cell Fate in Aging Mice
by: Na Wang, et al.
Published: (2021-12-01)

The Role of MYC and PP2A in the Initiation and Progression of Myeloid Leukemias
by: Raffaella Pippa, et al.
Published: (2020-02-01)

WHO 2016 Definition of Chronic Myeloid Leukemia and Tyrosine Kinase Inhibitors
by: İbrahim C. Haznedaroğlu, et al.
Published: (2020-02-01)

The Angiognic Chemokines Expression Profile of Myeloid Cell Lines Co-Cultured with Bone Marrow-Derived Mesenchymal Stem Cells
by: Karim Shamsasenjan, et al.
Published: (2018-01-01)

Shedding Light on Targeting Chronic Myeloid Leukemia Stem Cells
by: Mohammad Houshmand, et al.
Published: (2021-12-01)

CMTM3 suppresses bone formation and osteogenic differentiation of mesenchymal stem cells through inhibiting Erk1/2 and RUNX2 pathways
by: Dongwei Fan, et al.
Published: (2021-11-01)

Outcomes of Allogeneic Stem Cell Transplant in Chronic Myeloid Leukaemia - A Single-Centre Experience from Pakistan
by: Jehanzeb Rehman, et al.
Published: (2023-08-01)

Mesenchymal stem cells cause induction of granulocyte differentiation of rat bone marrow C-kit+ hematopoietic stem cells through JAK3/STAT3, ERK, and PI3K signaling pathways
by: Ezzatollah Fathi, et al.
Published: (2022-10-01)

Modulating retinoid-X-receptor alpha (RXRA) expression sensitizes chronic myeloid leukemia cells to imatinib in vitro and reduces disease burden in vivo
by: Bharathi M. Rajamani, et al.
Published: (2023-05-01)

Delayed acute pancreatitis induced by nilotinib in a patient with chronic myeloid leukemia attaining sustained complete molecular response
by: Shifang Wang, et al.
Published: (2020-07-01)

Current Views on the Interplay between Tyrosine Kinases and Phosphatases in Chronic Myeloid Leukemia
by: Christian Boni, et al.
Published: (2021-05-01)

(−)-Epigallocatechin-3-Gallate (EGCG) Enhances Osteogenic Differentiation of Human Bone Marrow Mesenchymal Stem Cells
by: Sung-Yen Lin, et al.
Published: (2018-12-01)

Evaluation of Electrolytes Disturbances in Iraqi Chronic Myeloid Leukemia Patients treated with Nilotinib with Monitoring of Response by FISH Study
by: Baghdad Science Journal
Published: (2015-03-01)

Targeting integrated stress response with ISRIB combined with imatinib treatment attenuates RAS/RAF/MAPK and STAT5 signaling and eradicates chronic myeloid leukemia cells
by: Wioleta Dudka, et al.
Published: (2022-12-01)

Acute Myeloid Leukemia Causes Serious and Partially Irreversible Changes in Secretomes of Bone Marrow Multipotent Mesenchymal Stromal Cells
by: Aleksandra Sadovskaya, et al.
Published: (2023-05-01)